IRWD | NASDAQ
$3.97
-$0.19 | -4.57%
SIGNAL:
|2026-09-28
|F&G 45
|RSI 42.0
|2026-09-28
|F&G 45
|RSI 42.0
Company Overview:
Market Cap:
$656.86M
Trailing PE:
5.2x
FWD PE *:
3.3x
Payout Ratio (TTM):
—
52-Week Range:
$1.29 - $5.78
* Forward PE is based on street estimates.
10 Year IRWD Performance Metrics:
Total Return (with DRIP):
-75.2% (-13.01% CAGR)
Total Return (no DRIP):
-75.2% (-13.01% CAGR)
Share Price:
-75.0% (-12.94% CAGR)
Yield on Cost (with DRIP):
—
Total Invested:
$10,000
Total Value (with DRIP):
$2,481
Total Return $ (with DRIP):
-$7,519
IRWD Total Return
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
IRWD Price Chart
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
All
Unlock All Reports & Research Dividend Stocks like a BOSS!
Save 25% with annual plan (3 Months Free)
Save 25% with annual plan (3 Months Free)
PRO
$19/mo
$11.40/mo
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $7.60 (40%)
Most Popular
PREMIUM
$32/mo
$19.20/mo
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $12.80 (40%)
ULTRA
$64/mo
$38.40/mo
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $25.60 (40%)
PRO
$171 ($14.25/mo)
$102.60/yr ($8.55/mo)
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo)
$172.80/yr ($14.40/mo)
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $211.20 (55%)
ULTRA
$576 ($48/mo)
$345.60/yr ($28.80/mo)
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $422.40 (55%)
IRWD Fundamentals: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:
IRWD Revenue CAGR:1Y: 32.62%2Y: 9.43%5Y: 1.68%10Y: 7.60%
IRWD EPS CAGR:1Y: 121.43%2Y: 0.00%5Y: -33.54%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
IRWD Net Income CAGR:1Y: 117.34%2Y: 0.00%5Y: -33.40%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
IRWD EBITDA CAGR:1Y: 73.51%2Y: 73.61%5Y: 4.41%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
IRWD Free Cash Flow CAGR:1Y: 0.00%2Y: 32.08%5Y: 3.71%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
IRWD Free Cash Flow / Share CAGR:1Y: 0.00%2Y: 29.48%5Y: 3.27%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
IRWD Operating Income CAGR:1Y: 75.96%2Y: 78.19%5Y: 4.03%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
IRWD Gross Profit CAGR:1Y: 33.35%2Y: 9.43%5Y: 4.24%10Y: 17.43%
🔓 See the full chart40% off right now · 7-day free trial
IRWD Shares Outstanding CAGR:1Y: 2.31%2Y: 2.01%5Y: 0.24%10Y: 1.35%
🔓 See the full chart40% off right now · 7-day free trial
IRWD Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
IRWD Stock-Based Comp CAGR:1Y: -28.47%2Y: -38.55%5Y: -6.75%10Y: -8.76%
🔓 See the full chart40% off right now · 7-day free trial
IRWD Expenses CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
🔓 See the full chart40% off right now · 7-day free trial
🔓 See the full chart40% off right now · 7-day free trial
🔓 See the full chart40% off right now · 7-day free trial
🔓 See the full chart40% off right now · 7-day free trial
🔓 See the full chart40% off right now · 7-day free trial
🔓 See the full chart40% off right now · 7-day free trial
IRWD Revenue CAGR:1Y: 32.62%2Y: 9.43%5Y: 1.68%10Y: 7.60%
🔓 See the full chart40% off right now · 7-day free trial
IRWD Revenue CAGR:1Y: 32.62%2Y: 9.43%5Y: 1.68%10Y: 7.60%
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
🔓 See the full chart40% off right now · 7-day free trial
IRWD Actual Revenue CAGR:1Y: 32.62%2Y: 9.43%5Y: 1.68%10Y: 7.60%
🔓 See the full chart40% off right now · 7-day free trial
IRWD Actual EPS CAGR:1Y: 121.43%2Y: 0.00%5Y: -33.54%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
IRWD Actual Net Income CAGR:1Y: 117.34%2Y: 0.00%5Y: -33.40%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
IRWD Actual EBITDA CAGR:1Y: 73.51%2Y: 73.61%5Y: 4.41%10Y: 0.00%
Ratios, Profit Margins & Return on Capital:
🔓 See the full chart40% off right now · 7-day free trial
IRWD Net Profit Margin CAGR:1Y: 63.85%2Y: 0.00%5Y: -34.49%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
IRWD Gross Profit Margin CAGR:1Y: 0.55%2Y: 0.00%5Y: 2.52%10Y: 9.14%
🔓 See the full chart40% off right now · 7-day free trial
IRWD Price to Earnings CAGR:1Y: 184.03%2Y: 0.00%5Y: 20.59%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
IRWD Price To Sales Ratio CAGR:1Y: 352.85%2Y: -25.10%5Y: -21.01%10Y: -15.90%
🔓 See the full chart40% off right now · 7-day free trial
IRWD Return on Capital Employed CAGR:1Y: -22.98%2Y: 109.92%5Y: 33.34%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
IRWD Return on Invested Capital CAGR:1Y: 140.25%2Y: 0.00%5Y: 26.81%10Y: 0.00%
Projected Future Returns & Dividends for IRWD
Based on past 10-year performance, here are IRWD growth metrics:
Share price CAGR of -12.94%
Dividend CAGR of +0%
Using IRWD CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| IRWD (DRIP) | IRWD - No DRIP | |
|---|---|---|
| Current Price | $3.97 | $3.97 |
| Start Shares | 2,518.89 | 2,518.89 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 2,518.89 | 2,518.89 |
| Dividends Payment | $0.00 | $0.00 |
| Annual Dividends | $0 | $0 |
| Yield on cost | 0.00% | 0.00% |
| Share Price | $0.99 | $3.97 |
| Total Dividends | $0 | $0 |
| Final Value | $2,500 | $10,000 |
Estimated Future Value + Dividends - IRWD
NOTE: Above numbers are our estimate based on IRWD's Dividend and Price CAGR over past 10 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Get the best Dividend Stock Research Tools:
Save 25% with annual plan (3 Months Free)
Save 25% with annual plan (3 Months Free)
PRO
$19/mo
$11.40/mo
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $7.60 (40%)
Most Popular
PREMIUM
$32/mo
$19.20/mo
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $12.80 (40%)
ULTRA
$64/mo
$38.40/mo
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $25.60 (40%)
PRO
$171 ($14.25/mo)
$102.60/yr ($8.55/mo)
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo)
$172.80/yr ($14.40/mo)
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $211.20 (55%)
ULTRA
$576 ($48/mo)
$345.60/yr ($28.80/mo)
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $422.40 (55%)
Company Info
Ironwood Pharmaceuticals, Inc. (IRWD) had its IPO on 2010-02-03, and is traded on NASDAQ stock exchange.
Ironwood Pharmaceuticals, Inc. operates as a healthcare enterprise primarily dedicated to discovering, developing, and commercializing therapeutic solutions for gastrointestinal (GI) conditions. Its flagship commercial product is linaclotide, a guanylate cyclase type-C (GC-C) agonist. This medication is prescribed for adult patients managing irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC), sold as LINZESS in the United States and Mexico, and under the CONSTELLA brand throughout Canada and the European Union. Beyond its marketed offerings, Ironwood's development pipeline includes IW-3300, another GC-C agonist targeting various visceral pain conditions, such as interstitial cystitis/bladder pain syndrome and endometriosis. Additionally, the company is advancing CNP-104, an immune nanoparticle being investigated for biliary cholangitis. Ironwood maintains key strategic alliances with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. to support the ongoing development and market introduction of linaclotide. Established in 1998, the Boston, Massachusetts-based firm initially operated as Microbia, Inc. before officially rebranding to Ironwood Pharmaceuticals, Inc. in April 2008.
IRWD website: https://www.ironwoodpharma.com
Get Full Access to All Reports with DRIPCalc PRO
Save 25% with annual plan (3 Months Free)
Save 25% with annual plan (3 Months Free)
PRO
$19/mo
$11.40/mo
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $7.60 (40%)
Most Popular
PREMIUM
$32/mo
$19.20/mo
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $12.80 (40%)
ULTRA
$64/mo
$38.40/mo
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $25.60 (40%)
PRO
$171 ($14.25/mo)
$102.60/yr ($8.55/mo)
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo)
$172.80/yr ($14.40/mo)
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $211.20 (55%)
ULTRA
$576 ($48/mo)
$345.60/yr ($28.80/mo)
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $422.40 (55%)
Loading signals…
DCF Model — IRWD
Value from:
🔒 Upgrade to unlock
The full DCF valuation — fair value, implied growth and the price path — is a paid feature.
Upgrade
Pay up to today
—
vs current price $3.97
—
Cash flow & implied price by year
FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.
EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.
Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
| Year | FCF | Implied price |
|---|
Sensitivity — fair value: growth ↓ × target return →
